Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

ECB. 2019; 8(1): 1-6


SYNTHESIS AND ANTICANCER EVALUATION OF NEW BENZENESULFONAMIDE DERIVATIVES

Rohini N. Shelke, Dattatraya N. Pansare, Chandraknat D. Pawar, Mininath C. Khade, Vrushali N. Jadhav, Satish U. Deshmukh, Ajit K. Dhas, Pravin N. Chavan, Aniket P. Sarkate, Rajendra P. Pawar, Devanand B. Shinde, Shankar R. Thopate.




Abstract

A highly efficient protocol was developed for the synthesis of 3-(indoline-1-carbonyl)-N-(substituted)benzenesulfonamide compounds with
excellent yields. The in vitro anticancer activity of the new 3-(indoline-1-carbonyl)-N-(substituted)benzenesulfonamide derivatives against
A549 (lung cancer cell), HeLa (cervical), MCF-7 (breast cancer cell) and Du-145 (prostate cancer cell) cell lines were studied. Most of the
tested compounds showed anticancer activity (IC50 values ranged between 1.98 and 9.12 µM against different cell lines).

Key words: Ind‾ sulfonamides; anticancer activity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.